Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients

Pharmacol Res. 2020 Sep:159:105043. doi: 10.1016/j.phrs.2020.105043. Epub 2020 Jun 20.

Authors

Hu-Dan Pan¹, Xiao-Jun Yao¹, Wan-Ying Wang¹, Hung-Yan Lau², Liang Liu³

Affiliations

¹ State Key Laboratory of Quality Research in Chinese Medicine/Macao, Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao, China.
² Queen Mary Hospital, Hong Kong, China.
³ State Key Laboratory of Quality Research in Chinese Medicine/Macao, Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao, China. Electronic address: lliu@must.edu.mo.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Drug Treatment
China / epidemiology
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Coronavirus Infections / metabolism
Drugs, Chinese Herbal / pharmacology*
Humans
Medicine, Chinese Traditional
Molecular Docking Simulation
Pandemics
Phytotherapy*
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / metabolism
Protein Interaction Maps
SARS-CoV-2
Transforming Growth Factor beta / chemistry
Transforming Growth Factor beta / metabolism

Substances

Drugs, Chinese Herbal
Transforming Growth Factor beta